About: covid:aae1603af1bb84087248441716a5c0bd373603b7

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:aae1603af1bb84087248441716a5c0bd373603b7 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Siqueira, Marilda Grinsztejn, Beatriz Santini-Oliveira, Marilia Ferreira, Ana Souza, Thiago Camacho, Luiz Carmem, B Giacoia-Gripp, Lemos, Alberto Luz, Paula Moreira, Ronaldo Morgado, Mariza Nunes, P Valdilé, Vasconcellos, Mauricio Veloso, G
is schema:about of	named entity 'DOUBLE' named entity 'human immunodeficiency virus (HIV)' named entity 'strategy' named entity 'Double' named entity 'IMMUNE RESPONSE' named entity 'PANDEMIC' named entity 'USING' named entity 'INFECTED' named entity 'PREVENTION STRATEGY' named entity 'PRESENT' named entity 'SINGLE' named entity 'VACCINATION' named entity 'DOUBLE' named entity 'RECOMMENDED' named entity 'ADULTS' named entity 'ADJUVANTED' named entity 'EVALUATE' named entity 'DOSES' named entity 'VACCINE' named entity 'DOSES' named entity 'ADJUVANTED' named entity 'RANDOMIZED TRIAL' named entity 'HIV' named entity 'VACCINATION' named entity 'SINGLE' named entity 'STUDY' named entity 'AIM' named entity 'SEVERE DISEASE' named entity 'PERSISTENCE' named entity 'ADULTS' named entity 'BACKGROUND' named entity 'IMMUNOGENICITY' named entity 'INCREASED RISK' named entity 'INDIVIDUALS' named entity 'SAFETY' named entity 'HUMAN IMMUNODEFICIENCY VIRUS' named entity 'RISK OF' named entity 'INFLUENZA A' named entity 'INFECTED' named entity 'aim' named entity 'persistence' named entity 'pandemic' named entity 'doses' named entity 'immunogenicity' named entity 'risk' named entity 'pandemic influenza' named entity 'human immunodeficiency virus' named entity 'HIV' named entity 'immune response' named entity 'vaccination' named entity 'vaccination' named entity 'antibody' named entity 'seroconversion' named entity 'H1N1pdm09' named entity 'influenza season' named entity 'HIV' named entity 'CD4 cell' named entity 'HIV' named entity 'Influenza' named entity 'viruses' named entity 'sample size' named entity 'rapid test' named entity 'seroconversion' named entity 'vaccination schedule' named entity 'virus' named entity 'GMT' named entity 'Brazil' named entity 'Luxembourg' named entity 'HIV' named entity 'rhinovirus' named entity 'vaccines' named entity 'CD4+' named entity 'hemagglutinins' named entity 'vaccine' named entity 'fever' named entity 'HIV/AIDS' named entity 'Brazil' named entity 'influenza vaccination' named entity 'H1N1pdm09' named entity 'glycosylated' named entity 'antigen' named entity 'H1N1pdm09' named entity 'viruses' named entity 'serum'

Attributes

Values

Creator

Siqueira, Marilda
Grinsztejn, Beatriz
Santini-Oliveira, Marilia
Ferreira, Ana
Souza, Thiago
Camacho, Luiz
Carmem, B
Giacoia-Gripp,
Lemos, Alberto
Luz, Paula
Moreira, Ronaldo
Morgado, Mariza
Nunes, P
Valdilé,
Vasconcellos, Mauricio
Veloso, G

is schema:about of

named entity 'DOUBLE'
named entity 'human immunodeficiency virus (HIV)'
named entity 'strategy'
named entity 'Double'
named entity 'IMMUNE RESPONSE'
named entity 'PANDEMIC'
named entity 'USING'
named entity 'INFECTED'
named entity 'PREVENTION STRATEGY'
named entity 'PRESENT'
named entity 'SINGLE'
named entity 'VACCINATION'
named entity 'DOUBLE'
named entity 'RECOMMENDED'
named entity 'ADULTS'
named entity 'ADJUVANTED'
named entity 'EVALUATE'
named entity 'DOSES'
named entity 'VACCINE'
named entity 'DOSES'
named entity 'ADJUVANTED'
named entity 'RANDOMIZED TRIAL'
named entity 'HIV'
named entity 'VACCINATION'
named entity 'SINGLE'
named entity 'STUDY'
named entity 'AIM'
named entity 'SEVERE DISEASE'
named entity 'PERSISTENCE'
named entity 'ADULTS'
named entity 'BACKGROUND'
named entity 'IMMUNOGENICITY'
named entity 'INCREASED RISK'
named entity 'INDIVIDUALS'
named entity 'SAFETY'
named entity 'HUMAN IMMUNODEFICIENCY VIRUS'
named entity 'RISK OF'
named entity 'INFLUENZA A'
named entity 'INFECTED'
named entity 'aim'
named entity 'persistence'
named entity 'pandemic'
named entity 'doses'
named entity 'immunogenicity'
named entity 'risk'
named entity 'pandemic influenza'
named entity 'human immunodeficiency virus'
named entity 'HIV'
named entity 'immune response'
named entity 'vaccination'
named entity 'vaccination'
named entity 'antibody'
named entity 'seroconversion'
named entity 'H1N1pdm09'
named entity 'influenza season'
named entity 'HIV'
named entity 'CD4 cell'
named entity 'HIV'
named entity 'Influenza'
named entity 'viruses'
named entity 'sample size'
named entity 'rapid test'
named entity 'seroconversion'
named entity 'vaccination schedule'
named entity 'virus'
named entity 'GMT'
named entity 'Brazil'
named entity 'Luxembourg'
named entity 'HIV'
named entity 'rhinovirus'
named entity 'vaccines'
named entity 'CD4+'
named entity 'hemagglutinins'
named entity 'vaccine'
named entity 'fever'
named entity 'HIV/AIDS'
named entity 'Brazil'
named entity 'influenza vaccination'
named entity 'H1N1pdm09'
named entity 'glycosylated'
named entity 'antigen'
named entity 'H1N1pdm09'
named entity 'viruses'
named entity 'serum'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software